BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · IEX Real-Time Price · USD
14.64
+0.27 (1.88%)
At close: Aug 12, 2022 4:00 PM
14.71
+0.07 (0.48%)
After-hours: Aug 12, 2022 7:57 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 1994
Revenue
157.1717.8148.8420.6525.1926.3548.2613.6117.3326.29
Upgrade
Revenue Growth (YoY)
782.38%-63.53%136.45%-18.00%-4.43%-45.39%254.62%-21.48%-34.09%33.85%
Upgrade
Cost of Revenue
7.261.684.10.471.72.71.90.120.10.13
Upgrade
Gross Profit
149.9116.1444.7320.1823.4823.6546.3613.4917.2326.16
Upgrade
Selling, General & Admin
118.8267.9337.1229.5113.9311.2513.057.466.019.13
Upgrade
Research & Development
208.81122.96107.0784.8966.9661.0172.7651.841.9449.16
Upgrade
Other Operating Expenses
0000000001.76
Upgrade
Operating Expenses
327.63190.89144.19114.480.972.2685.8159.2647.9560.05
Upgrade
Operating Income
-177.72-174.76-99.46-94.22-57.41-48.61-39.44-45.77-30.72-33.89
Upgrade
Interest Expense / Income
59.2914.511.899.188.576.495.254.784.67
Upgrade
Other Expense / Income
-55.21-6.44-2.45-2.14-0.190.05-1.63-5.58-5.390.53
Upgrade
Pretax Income
-181.81-182.81-108.9-101.25-65.78-55.14-43.02-45.19-30.11-39.08
Upgrade
Income Tax
2.25000000000
Upgrade
Net Income
-184.06-182.81-108.9-101.25-65.78-55.14-43.02-45.19-30.11-39.08
Upgrade
Net Income Common
-184.06-182.81-108.9-101.25-65.78-55.14-43.02-45.19-30.11-39.08
Upgrade
Shares Outstanding (Basic)
179167116103847473675549
Upgrade
Shares Outstanding (Diluted)
179167116103847473675549
Upgrade
Shares Change
7.08%44.70%12.03%22.18%14.59%1.09%9.18%20.93%11.61%9.59%
Upgrade
EPS (Basic)
-1.03-1.09-0.94-0.98-0.78-0.75-0.59-0.68-0.55-0.79
Upgrade
EPS (Diluted)
-1.03-1.09-0.94-0.98-0.78-0.75-0.59-0.68-0.55-0.79
Upgrade
Free Cash Flow Per Share
-0.81-0.81-0.78-0.90-0.49-0.80-0.25-0.58-0.48-0.76
Upgrade
Gross Margin
95.40%90.60%91.60%97.70%93.20%89.80%96.10%99.10%99.40%99.50%
Upgrade
Operating Margin
-113.10%-981.10%-203.70%-456.20%-227.90%-184.40%-81.70%-336.40%-177.20%-128.90%
Upgrade
Profit Margin
-117.10%-1026.40%-223.00%-490.30%-261.20%-209.30%-89.10%-332.10%-173.70%-148.60%
Upgrade
Free Cash Flow Margin
-92.00%-761.40%-184.10%-450.00%-164.60%-222.80%-37.80%-284.10%-153.00%-142.70%
Upgrade
Effective Tax Rate
-1.24%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Upgrade
EBITDA
-121.74-167.57-96.28-91.31-56.51-48.17-37.64-40.01-25.03-33.79
Upgrade
EBITDA Margin
-77.50%-940.70%-197.20%-442.10%-224.40%-182.80%-78.00%-294.00%-144.40%-128.50%
Upgrade
Depreciation & Amortization
0.780.750.720.770.70.480.180.180.30.63
Upgrade
EBIT
-122.52-168.31-97.01-92.08-57.22-48.66-37.82-40.19-25.33-34.42
Upgrade
EBIT Margin
-78.00%-944.90%-198.60%-445.80%-227.20%-184.60%-78.40%-295.30%-146.20%-130.90%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).